Crosstalk of osteoblast and osteoclast precursors on mineralized collagen-towards an in vitro model for bone remodeling

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 3 A, 2010, Pages 848-856

  Bernhardt, A ^a   Thieme, S ^b   Domaschke, H ^b   Springer, A ^a   Rosen Wolff A ^b,c   Gelinsky, M ^a,c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

Bone remodeling; Coculture; Monocytes; MSC; Osteoblast; Osteoclast

Indexed keywords

BONE REMODELING; COCULTURE; MONOCYTES; MSC; OSTEOCLAST;

BODY FLUIDS; BONE; CELL CULTURE; COLLAGEN; OSTEOBLASTS; PHOSPHATASES; SELF ASSEMBLY; STEM CELLS; TRANSMISSION ELECTRON MICROSCOPY;

GENE EXPRESSION;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1;

ARTICLE; BONE MATRIX; BONE REGENERATION; BONE REMODELING; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE STRUCTURE; MESENCHYMAL STEM CELL; MONOCYTE; NORMAL HUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; BIOCOMPATIBLE MATERIALS; BONE REMODELING; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; EXTRACELLULAR MATRIX; HUMANS; ISOENZYMES; MATERIALS TESTING; MESENCHYMAL STEM CELLS; MONOCYTES; NANOCOMPOSITES; OSTEOBLASTS; OSTEOCLASTS;

EID: 78249280264     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32856     Document Type: Article

References (42)

1. Domaschke H, Gelinsky M, Burmeister B, Fleig R, Hanke T, Reinstorf A, Pompe W, Rosen-Wolff A,. In vitro ossification and remodeling of mineralized collagen I scaffolds. Tissue Eng 2006; 12: 949 -958.
2. Tortelli F, Pujic N, Liu Y, Laroche N, Vico L, Cancedda R,. Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. Tissue Eng Part A 2009; 15: 2373 -2383.
3. Owen M,. Marrow stromal stem cells. J Cell Sci Suppl 1988; 10: 63 -76.
4. Caplan AL,. Mesenchymal stem cells. J Orthop Res 1991; 9: 641 -650.
5. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143 -147.
6. Sata M, Tanaka K, Nagai R,. Circulating osteoblast-lineage cells. N Engl J Med 2005; 353: 737 -738.
7. Koshla S, Eghbali-Fatourechi GZ,. Circulating cells with osteogenic potential. Ann N Y Acad Sci 2006; 1068: 489 -497
8. Eghbali-Fatourechi GZ, Mödder UIL, Charatcharoenwitthaya N, Sanyal A, Undale AH, Clowes JA, Tarara JE, Khosla S,. Characterization of circulating osteoblast lineage in humans. Bone 2007; 40: 1370 -1377; erratum: 2007;41:741.
9. Ash P, Loutit JF, Townsend KM,. Osteoclasts derived from haematopoietic stem cells. Nature 1980; 283: 669 -670.
10. Bar-Shavit Z,. The osteoclast: A multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem 2007; 102: 1130 -1139.
11. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA,. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996; 137: 4058 -4060.
12. Quinn JM, Neale S, Fujikawa Y, McGee JO, Athanasou NA,. Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif Tissue Int 1998; 62: 527 -531.
13. Massey HM, Flanagan AM,. Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 1999; 106: 167 -170.
14. Sabokbar A, Athanasou NS,. Generating human osteoclasts from peripheral blood. Methods Mol Med 2003; 80: 101 -111.
15. Buckley KA, Chan BY, Fraser WD, Gallagher JA,. Human osteoclast culture from peripheral blood monocytes: Phenotypic characterization and quantitation of resorption. Methods Mol Med. 2005; 107: 55 -68.
16. Sørensen MG, Henriksen K, Schaller S, Henriksen DB, Nielsen FC, Dziegiel MH, Karsdal MA,. Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab 2007; 25: 36 -45.
17. Asagiri M, Takayanagi H, The molecular understanding of osteoclast differentiation. Bone 2007; 40: 251 -264.
18. Bradt JH, Mertig M, Teresiak A, Pompe W,. Biomimetic mineralization of collagen by combined fibril assembly and calcium phosphate formation. Chem Mater 1999; 11: 2694 -2701.
19. M. Gelinsky,. Mineralised collagen as biomaterial and matrix for bone tissue engineering. In:, Meyer U, Meyer TH, Handschel J, Wiesmann H-P, editors. Fundamentals of Tissue Engineering and Regenerative Medicine. Chapter 36. Heidelberg and Berlin: Springer; 2009. p 485 -493.
20. Burth R, Gelinsky M, Pompe W,. Collagen-hydroxyapatite tapes-A new implant material. Tech Textile 1999; 8: 20 -21.
21. Bernhardt A, Lode A, Boxberger S, Pompe W, Gelinsky M,. Mineralised collagen-An artificial, extracellular bone matrix-Improves osteogenic differentiation of bone marrow stromal cells. J Mater Sci Mater Med 2008; 19: 269 -275.
22. Gelinsky M, Welzel PB, Simon P, Bernhardt A., König U,. Porous three dimensional scaffolds made of mineralised collagen: Preparation and properties of a biomimetic nanocomposite material for tissue engineering of bone. Chem Eng J 2008; 137: 84 -96.
23. Gelinsky M, König U, Sewing A, Pompe W,. Porous scaffolds made from mineralised collagen-A biomimetic bone graft material. Mat.-wiss. u. Werkstofftech 2004; 35: 229 -233.
24. Lau KH, Onishi T, Wergedal JE, Singer FR, Baylink DJ,. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem 1987; 33: 458 -462.
25. Janckila AJ, Takahashi K, Sun SZ, Yam LT,. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 2001; 47: 74 -80.
26. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T,. Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988; 123: 2600 -2602.
27. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T,. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: Receptor activator of NF-kappa B ligand. Bone 1999; 25: 517 -523.
28. Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC,. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. J Cell Physiol 2005; 203: 573 -582.
29. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T,. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 1998; 246: 199 -204.
30. Kreja L, Liedert A, Schmidt C, Claes L, Ignatius A,. Influence of receptor activator of nuclear factor (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteoclast formation and activity. J Mol Histol 2007; 38: 341 -345.
31. Perrotti V, Nicholls BM, Piattelli A,. Human osteoclast formation and activity on an equine spongy bone substitute. Clin Oral Implants Res 2009; 20: 17 -23.
32. Deyama Y, Takeyama S, Koshikawa M, Shirai Y, Yoshimura Y, Nishikata M, Suzuki K, Matsumoto A,. Osteoblast maturation suppressed osteoclastogenesis in coculture with bone marrow cells. Biochem Biophys Res Commun 2000; 274: 249 -254.
33. Takeyama S, Yoshimura Y, Deyama Y, Sugawara Y, Fukuda H, Matsumoto A,. Phosphate decreases osteoclastogenesis in coculture of osteoblast and bone marrow. Biochem Biophys Res Commun 2001; 282: 798 -802.
34. Mbalaviele G, Jaiswal N, Meng A, Cheng L, Van Den Bos C, Thiede M,. Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology 1999; 140: 3736 -3743.
35. Galvin RJ, Cullison JW, Avioli LV, Osdoby PA,. Influence of osteoclasts and osteoclast-like cells on osteoblast alkaline phosphatase activity and collagen synthesis. J Bone Miner Res 1994; 9: 1167 -1178.
36. Zhu M, Zhang P, Zhang X, Lu B, Dai CL, Li YM, Qiu MC,. [Impact of osteoclast-like cells cultured on bone wafer and their sub-cellular structures on osteoblast]. Zhonghua Yi Xue Za Zhi 2005; 23: 738 -742.
37. Hung SC, Chang CF, Ma HL, Chen TH, Low-Tone Ho L,. Gene expression profiles of early adipogenesis in human mesenchymal stem cells. Gene 2004; 340: 141 -150.
38. Tomlinson JJ, Boudreau A, Wu D, Atlas E, Haché RJ,. Modulation of early human preadipocyte differentiation by glucocorticoids. Endocrinology 2006; 147: 5284 -5293.
39. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME,. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992; 102 (Pt 2): 341 -351.
40. Kang S, Bennett CN, Gerin I, Rapp LA, Hankenson KD, Macdougald OA,. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J Biol Chem 2007; 282: 14515 -14524.
41. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B,. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004; 3: 379 -389.
42. Kim YH, Jun JH, Woo KM, Ryoo HM, Kim GS, Baek JH,. Dexamethasone inhibits the formation of multinucleated osteoclasts via down-regulation of beta3 integrin expression. Arch Pharm Res 2006; 29: 691 -698.